-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Head-To-Head Comparison: Avantor (NYSE:AVTR) & Seer (NASDAQ:SEER)
Head-To-Head Comparison: Avantor (NYSE:AVTR) & Seer (NASDAQ:SEER)
Avantor (NYSE:AVTR – Get Rating) and Seer (NASDAQ:SEER – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, analyst recommendations, profitability and dividends.
Analyst Ratings
This is a summary of current recommendations and price targets for Avantor and Seer, as provided by MarketBeat.com.
Get Avantor alerts:Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Avantor | 0 | 4 | 10 | 0 | 2.71 |
Seer | 0 | 2 | 1 | 0 | 2.33 |
Avantor currently has a consensus target price of $33.43, suggesting a potential upside of 67.06%. Seer has a consensus target price of $13.00, suggesting a potential upside of 65.39%. Given Avantor's stronger consensus rating and higher probable upside, equities analysts plainly believe Avantor is more favorable than Seer.
Earnings & Valuation
This table compares Avantor and Seer's top-line revenue, earnings per share and valuation.Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Avantor | $7.39 billion | 1.83 | $572.60 million | $0.93 | 21.52 |
Seer | $6.62 million | 74.14 | -$71.17 million | ($1.37) | -5.74 |
Avantor has higher revenue and earnings than Seer. Seer is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Avantor has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. Comparatively, Seer has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500.
Institutional and Insider Ownership
81.2% of Avantor shares are owned by institutional investors. Comparatively, 75.9% of Seer shares are owned by institutional investors. 1.6% of Avantor shares are owned by insiders. Comparatively, 18.0% of Seer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Avantor and Seer's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Avantor | 8.27% | 27.14% | 7.18% |
Seer | -695.94% | -17.12% | -16.03% |
Summary
Avantor beats Seer on 11 of the 14 factors compared between the two stocks.
About Avantor
(Get Rating)
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
About Seer
(Get Rating)
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
Avantor (NYSE:AVTR – Get Rating) and Seer (NASDAQ:SEER – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, analyst recommendations, profitability and dividends.
埃文特(NYSE:AVTR-GET Rating)和赛尔(纳斯达克:SEER-GET Rating)都是医药公司,但哪只股票更好?我们将根据这两家公司的估值、风险、收益、机构所有权、分析师建议、盈利能力和股息的实力进行比较。
Analyst Ratings
分析师评级
This is a summary of current recommendations and price targets for Avantor and Seer, as provided by MarketBeat.com.
这是MarketBeat.com提供的对Avantor和Seer的当前建议和目标价的摘要。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Avantor | 0 | 4 | 10 | 0 | 2.71 |
Seer | 0 | 2 | 1 | 0 | 2.33 |
销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
复仇者 | 0 | 4 | 10 | 0 | 2.71 |
先知 | 0 | 2 | 1 | 0 | 2.33 |
Avantor currently has a consensus target price of $33.43, suggesting a potential upside of 67.06%. Seer has a consensus target price of $13.00, suggesting a potential upside of 65.39%. Given Avantor's stronger consensus rating and higher probable upside, equities analysts plainly believe Avantor is more favorable than Seer.
Avantor目前的共识目标价为33.43美元,暗示潜在上行67.06%。Seer的普遍目标价为13.00美元,暗示潜在上涨65.39%。考虑到Avantor更高的共识评级和更高的可能上行空间,股票分析师显然认为Avantor比Seer更有利。
Earnings & Valuation
收益与估值
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Avantor | $7.39 billion | 1.83 | $572.60 million | $0.93 | 21.52 |
Seer | $6.62 million | 74.14 | -$71.17 million | ($1.37) | -5.74 |
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
复仇者 | 73.9亿美元 | 1.83 | 5.726亿美元 | $0.93 | 21.52 |
先知 | 662万美元 | 74.14 | -7,117万美元 | ($1.37) | -5.74 |
Avantor has higher revenue and earnings than Seer. Seer is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.
Avantor的收入和收益比Seer更高。Seer的市盈率低于Avantor,这表明它目前是两只股票中更负担得起的一只。
Volatility and Risk
波动性和风险
Avantor has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. Comparatively, Seer has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500.
Avantor的贝塔系数为1.34,这表明其股价的波动性比标准普尔500指数高34%。相比之下,Seer的贝塔系数为1.74,这表明其股价的波动性比标准普尔500指数高出74%。
Institutional and Insider Ownership
机构和内部人持股
81.2% of Avantor shares are owned by institutional investors. Comparatively, 75.9% of Seer shares are owned by institutional investors. 1.6% of Avantor shares are owned by insiders. Comparatively, 18.0% of Seer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Avantor 81.2%的股份由机构投资者持有。相比之下,SEER 75.9%的股份由机构投资者持有。Avantor 1.6%的股份由内部人士持有。相比之下,Seer 18.0%的股份由内部人士持有。强大的机构持股表明,对冲基金、大型基金管理公司和捐赠基金相信,一只股票有望实现长期增长。
Profitability
盈利能力
This table compares Avantor and Seer's net margins, return on equity and return on assets.
下表比较了埃文特和赛尔的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Avantor | 8.27% | 27.14% | 7.18% |
Seer | -695.94% | -17.12% | -16.03% |
净利润率 | 股本回报率 | 资产回报率 | |
复仇者 | 8.27% | 27.14% | 7.18% |
先知 | -695.94% | -17.12% | -16.03% |
Summary
摘要
Avantor beats Seer on 11 of the 14 factors compared between the two stocks.
在两只股票比较的14个因素中,埃万托有11个击败了Seer。
About Avantor
关于Avantor
(Get Rating)
(获取评级)
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Avantor,Inc.为美洲、欧洲、亚洲、中东和非洲的生物制药、医疗保健、教育和政府、先进技术和应用材料行业的客户提供产品和服务。该公司提供材料和消耗品,如纯度化学品和试剂、实验室产品和用品、配方硅材料、定制辅料、定制一次性组件、过程色层树脂和色谱柱、分析样品制备试剂盒、教育和微生物学产品、临床试验试剂盒、蠕动泵和流体处理提示。它还提供设备和仪器产品,包括过滤系统、病毒灭活系统、孵化器、分析仪器、蒸发器、超低温冰柜、生物安全柜和关键环境用品。此外,该公司还提供服务和专业采购,包括现场实验室和生产、临床、设备、采购和采购,以及生物制药材料的扩大和开发服务。Avantor,Inc.成立于1904年,总部设在宾夕法尼亚州拉德诺市。
About Seer
关于Seer
(Get Rating)
(获取评级)
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
SEER,Inc.是一家生命科学公司,致力于开发和商业化产品,以破译蛋白质组的秘密。它开发了蛋白质图谱产品套件,这是一种集成的解决方案,包括消耗品、自动化仪器和软件,使研究人员能够在治疗和诊断研究以及临床试验中进行蛋白质组研究。该公司打算将其产品用于研究目的,包括学术机构、生命科学和研究实验室,以及用于非诊断和非临床目的的生物制药和生物技术公司。它与探索生命科学有限责任公司达成了一项合作协议。和索尔克生物研究所。该公司前身为Seer Biosciences,Inc.,于2018年7月更名为Seer,Inc.。SEER,Inc.成立于2017年,总部位于加利福尼亚州雷德伍德城。
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
接受《复仇者日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Avantor和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧